Cleared Traditional

K820265 - ANA TEST (MOUSE LIVER SUBSTRATE)

K820265 is an FDA 510(k) clearance for ANA TEST (MOUSE LIVER SUBSTRATE), manufactured by Meloy Laboratories, Inc.. The device is a Class 2 Immunology device with product code DHN cleared through the Traditional 510(k) pathway after a 10-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1982
Decision
10d
Days
Class 2
Risk

K820265 is an FDA 510(k) clearance for the ANA TEST (MOUSE LIVER SUBSTRATE). Classified as Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control (product code DHN), Class II - Special Controls.

Submitted by Meloy Laboratories, Inc. (Mchenry, US). The FDA issued a Cleared decision on February 12, 1982 after a review of 10 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K820265

510(k) Number K820265 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 1982
Decision Date February 12, 1982
Days to Decision 10 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 105d · This submission: 10d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHN Device Classification - Class 2, Special Controls

Product Code DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

All 109
Devices cleared under the same product code (DHN) and FDA review panel - the closest regulatory comparables to K820265.
SERA FOR ANTINUCLEAR ANTIBODIES
K820945 · Centers For Disease Control and Prevention · Oct 1982
ANA HEP-2 FLUORO-KIT
K822397 · Clinical Sciences, Inc. · Sep 1982
ANTINUCLEAR ANTOBODY CELL SUBSTRATE
K822607 · Immulok, Inc. · Sep 1982
QUANTAFLUOR FLUORESCENT TEST REAGENTS
K813592 · Kallestad Laboratories, Inc. · Jan 1982
CRITHIDNA ANTI-DNA TEST KIT
K812314 · Antibodies, Inc. · Sep 1981
HEP-2-CRITHIDIA LUCILIAE ANA TEST KIT
K811714 · Scripps-Miles, Inc. · Jul 1981